Earnings Play: HCA Healthcare
Jason Lubin October 24, 2020 2:15 AM
Look for a breakout from the symmetrical triangle pattern.
On Monday, before market, HCA Healthcare (HCA) is anticipated to report third quarter EPS of $2.28 compared to $2.23 a year ago on revenue of approximately $13.0 billion vs. $12.7 billion last year. HCA Healthcare is one of the largest for-profit hospital operators in the U.S. and its current analyst consensus rating is 17 buys, 7 holds and 0 sells, according to Bloomberg.
Looking at a daily chart, HCA Healthcare's stock price appears to have formed a intermediate-term symmetrical triangle pattern that began to form in the early months of 2020. On a more short-term basis the company has been advancing in an uptrend since late September. Price is currently being stopped at the upper trendline of the symmetrical triangle and in the last 5 days of trading most of the candle sticks have formed short real bodies with long wicks hinting at indecision. The RSI is showing divergence as price made a slightly higher high in October than it did in early September and the RSI made a lower high. Price will likely begin a new short-term downtrend and head for 114.00. Price will probably find support at 114.00 and chop around before reaching for 101.00. On the other hand, if price can manage to get over 140.00 then it could retest the record high of roughly 152.00. If price gets above 152.00, then it could continue to rise.
Source: GAIN Capital, TradingView
From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.